[Congressional Record Volume 142, Number 24 (Tuesday, February 27, 1996)]
[Daily Digest]
[Pages D105-D106]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
(Committees not listed did not meet)
RAIL SAFETY
Committee on Commerce, Science, and Transportation: Committee concluded 
hearings to examine the safety of the United States rail network, after 
receiving testimony from Senators Lautenberg and Mikulski; 
Representative Wynn; James E. Hall, Chairman, and Bob Laubey, Head, 
Rail Division, both of the National Transportation Safety Board; Jolene 
M. Molitoris, Administrator, and Grady Cothen, Associate Administrator 
of Safety Standards, both of the Federal Railroad Administration, and 
Grace Crunican, Deputy Administrator, Federal Transit Administration, 
both of the Department of Transportation; Thomas M. Downs, National 
Railroad Passenger Corporation, Edwin L. Harper, Association of 
American Railroads, and Ronald P. McLaughlin, Brotherhood of Locomotive 
Engineers, all of Washington, D.C.; and Thomas F. Prendergast, 
Metropolitan Transit Authority Long Island Rail Road, Jamaica Station, 
New York, on behalf of the American Public Transit Association.
TRAVEL BAN TO LEBANON
Committee on Foreign Relations: Subcommittee on Near Eastern and South 
Asian Affairs concluded hearings on proposals to prohibit United States 
citizens from travelling to Lebanon, including a related measure, S. 
Res. 202, after receiving testimony from Senators Graham and Abraham; 
Representatives Rahall, Hoke, and LaHood; former Senator Percy; Robert 
H. Pelletreau, Assistant Secretary of State for Near Eastern Affairs; 
Bruce O. Riedel, Deputy Assistant Secretary of Defense for Near Eastern 
and South Asian Affairs; former U.S. Ambassador to Bahrain Sam Zakhem; 
Peter J. Tanous, American Task Force for Lebanon, Ralph R. DiSibio, 
Parsons Corporation, and Khalil E. Jahshan, National Association of 
Arab Americans, all of Washington, D.C.; and Casey Kasem, Los Angeles, 
California.

[[Page D106]]

NOMINATION
Committee on the Judiciary: Committee concluded hearings on the 
nomination of Barry R. McCaffrey, of Washington, to be Director of 
National Drug Control Policy, after the nominee, who was introduced by 
Senators Warner and Nunn, testified and answered questions in his own 
behalf.
PHARMACEUTICAL PATENT PROTECTION
Committee on the Judiciary: Committee held hearings to examine the 
interrelationship between the intellectual property provisions of the 
GATT Treaty implementing law and food and drug law and its impact on 
the creation of new breakthrough drugs and production of lower cost 
generic copies, and S. 1277, to provide equitable relief for the 
generic drug industry, receiving testimony from Senators Pryor, 
Faircloth, and Chafee; Michael Kantor, United States Trade 
Representative; William E. Brock, The Brock Group, former U.S. Trade 
Representative, Gerald J. Mossinghoff, former Commissioner, Patent and 
Trademark Office, and Charles J. Cooper, Shaw, Pittman, Potts & 
Trowbridge, both on behalf of the Pharmaceutical Research and 
Manufacturers of America, and James P. Firman, National Council on the 
Aging, on behalf of the Generic Drug Equity Coalition, all of 
Washington, D.C.; Robert J. Gunter, Novopharm USA, Schaumburg, 
Illinois, on behalf of the National Pharmaceutical Alliance; and Judith 
Simpson, United Patients' Association for Pulmonary Hypertension, 
DeKalb, Illinois.
  Hearings continue on Tuesday, March 5.
FAIR LABOR STANDARDS REFORM
Committee on Labor and Human Resources: Committee concluded oversight 
hearings on the implementation of the Fair Labor Standards Act and its 
impact on workplace flexibility, after receiving testimony from Senator 
Ashcroft; Maggi Coil, Motorola, Shaumberg, Illinois, and John H. 
Shamley, Washington, D.C., both on behalf of the American Compensation 
Association; Arlyce Robinson, Computer Sciences Corporation, Falls 
Church, Virginia; Phyllis G. Diosey, Malcolm Pirnie, Inc., White 
Plains, New York; E. Glenn Baker, John Alden Life Insurance Company, 
Miami, Florida; Douglas P. Kight, Boeing Company, Seattle, Washington; 
and Michael T. Leibig, Zwerdling, Paul, Leibig, Kahn, Thompson & Wolly, 
Fairfax, Virginia.